You Searched For "remdesivir maker" and got 19 results
Sort By:
Thanks to Remdesivir, Kwality Pharma’s stock is up from ₹59 to over ₹922 in just over nine months
Stocks of drug makers have been on a tear but none more than the Punjab-based Kwality Pharmaceutica…
Alexandria Ocasio-Cortez says it's 'absolutely wild' that senators can trade stocks after Rand Paul discloses controversial Gilead purchase
The politician said members of Congress should not be able to trade stocks after Rand Paul disclose…
Harry Robertson
Favipiravir shortage may get filled up in a couple of weeks provided people don't hoard
Like Sheth, Varun Mimani, the Head of Supply Chain at 1mg said that the severity and natur…
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
Steroids can seriously reduce risk of death from COVID-19, new trials show. WHO is strongly recommending them.
Research published this week shows steroids may be the most effective drugs for serious cases of co…
Susie Neilson
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
Dr Reddy's inks pact with Gilead to manufacture COVID-19 drug Remdesivir
The company will receive technology transfer from Gilead for manufacturing of the drug, it added…
PTI
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
OPPO A74 smartphone with 5G support and 90Hz display to launch in India soon, to be priced under ₹20,000
Smartphone maker OPPO on Friday said that it is all set to launch A74 5G in India on April 20.
Indian-American researcher identifies 4 possible treatments for COVID-19
An Indian-American scientist-led team from the University of Missouri has found that four antiviral…
After Maharashtra and Delhi, Rajasthan government announces weekend curfew to curb the spread of COVID-19
In view of the rising Covid-19 cases, the Rajasthan government has announced a weekend curfew in th…
India's vaccine providers can charge $10 to $32 for coronavirus shots amid the country's unprecedented surge
Charging for shots could prevent many Indians - particularly poorer residents - from getting vaccin…
Aria Bendix
Patients rush to join studies testing drug for coronavirus
Gilead supplied remdesivir for two studies in China expected to give results by the end of the mont…
PTI
Sensex jumps over 150 points in early trade, Nifty tests 14,650 — UltraTech Cement, Asian Paints, HCL Tech, HDFC, Tech Mahindra and M&M top gainers
The 30-share BSE index was trading 160.43 points or 0.33 per cent higher at 48,964.11. On…
PTI
₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500— here’s why
Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…
Checkout what is allowed and what is not in the new guidelines issued by the Delhi government
The Arvind Kejriwal-led Delhi state government has imposed a weekend curfew from April 16 (Friday) …
Eli Lilly has ended a major COVID-19 antibody test among hospitalized patients
Eli Lilly said it would continue trials of the antibody treatment with patients who have milder for…